title: Letter: Immunocryotherapy for difficult-to-treat basal cell carcinoma of the eyelid.
authors.forename: Zoe
authors.initials: Z
authors.lastname: Apalla
authors.forename: Anatoli
authors.initials: A
authors.lastname: Karteridou
authors.forename: Aimilios
authors.initials: A
authors.lastname: Lallas
authors.forename: Thrasivoulos
authors.initials: T
authors.lastname: Tzellos
authors.forename: Ioanna
authors.initials: I
authors.lastname: Lefaki
authors.forename: Elena
authors.initials: E
authors.lastname: Sotiriou
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Varytimiadis
mesh_terms: D000634:Aminoquinolines / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000628:therapy*; D003131:Combined Modality Therapy; D003452:Cryosurgery; D005142:Eyelid Neoplasms / Q000628:therapy*; D006801:Humans; D000077271:Imiquimod; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000628:therapy*
chemical_list: D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod